Abstract
2006;64:226–33. [12] Mehta S, Giovannucci E, Mugusi FM, et al. Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS ONE 2010;5:e8770. [13] Mueller NJ, Fux CA, Ledergerber B, et al, Swiss HIV Cohort Study. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS 2010;24:1127–34. [14] Bang UC, Shakar SA, HitzMF, et al. Deficiency of 25-hydroxyvitamin D inmale HIVpositive patients: a descriptive cross-sectional study. Scand J Infect Dis 2010;42:306–10. [15] Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008;24:1375–82. [16] MelamedML, Michos ED, PostW, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008;168:1629–37. [17] Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008;168:1174–80. [18] Shewan LG, Coats AJ. Ethics in the authorship and publishing of scientific articles. Int J Cardiol 2010;144:1–2. [19] Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009;131:149–50.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call